About Psilocybin Therapy
An overview of investigational psilocybin therapy and how it is being studied for mental health conditions. It explains the treatment process, including preparation, the dosing session, and integration.
Provider
COMPASS Pathways
English
Schedule
8 hours
Enrollment
Price on requestCourse Overview
This page explains investigational psilocybin therapy, also described as psilocybin treatment, and how it is being studied with psychological support for certain mental health conditions. It notes that COMPASS Pathways has developed an investigational synthesised formulation of psilocybin called COMP360. The content covers what happens during psilocybin therapy, including preparation, the dosing session, and integration afterward. It describes the session environment, the role of the therapist, and the use of music and an eye mask during the experience. The page is primarily informational and also outlines COMPASS Pathways’ clinical development programme and the conditions being researched, including treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa.
Who is this for?
People seeking an overview of investigational psilocybin therapy, including those interested in mental health research and treatment development.
About the Provider
COMPASS Pathways is a UK-listed biopharmaceutical company developing COMP360 synthetic psilocybin therapy for treatment-resistant depression, with two successful Phase 3 trials making it the leading candidate for the first regulatory approval of a classic psychedelic medicine.